General Public
The Difference Between Latent TB Infection and Active TB Disease
This information sheet discusses tuberculosis (TB) and the difference between the two TB-related conditions: latent TB infection (LTBI) and TB disease. It explains what is meant by LTBI, and, that although persons with LTBI cannot spread the disease, if left untreated, they can develop active TB in the future. The information sheet also describes active TB disease, its symptoms, and the need for treatment.
TB Medication Fact Sheets (French)
This series of patient education fact sheets provides information on drugs used in the treatment of TB (e.g., Clofazimine, Ethambutol, Ethionamide, Isoniazid, Levofloxacin, Moxifloxacin, PASER [p-aminosalicylic acid granules], Pyrazinamide, Pyridoxine, Rifabutin, Rifampin, Streptomycin). The fact sheets include information on medication side effects, actions to take if side effects occur, and instructions in the event a dose of medication is missed.
World TB Day 2018
The Stop TB Partnership has developed a set of campaign materials for World TB Day 2018.
TB Elimination: Diagnosis of Tuberculosis Disease
This information sheet discusses the steps taken to diagnose TB disease. It describes the symptoms of TB and explains how an individual suspected of having TB is evaluated using the following: medical history, physical examination, skin test or special TB blood test, chest radiograph, microbiological tests, and finally tests for drug resistance.
Testing for Tuberculosis (TB)
In a question and answer format, this information sheet discusses testing for tuberculosis (TB). There are two kinds of tests that are used to determine if a person has been infected with TB bacteria: the tuberculin skin test (TST) and TB blood tests.
Hepatitis C Medications: A Review and Update for Patients
TB Elimination: BCG Vaccine
This information sheet discusses the bacille Calmette-Guerin (BCG) vaccine for TB disease, which is used in many countries to prevent childhood tuberculous meningitis and miliary disease. It explains why the BCG is not generally recommended for use in the United States; suggests that the BCG should be considered under specific circumstances; and provides recommendations for when the BCG should be used with children and health care workers and contraindications when it should not be used, such as for immunosuppressed persons and pregnant women.